Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

FTC Approves Final Consent Order in Ascension Health-AmSurg Deal

25 August 2026 · By · Wire by Fusion42

Published

25 August 2026

Topic

regulatory

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at ftc.gov →

◆ Verified

Fusion42 · 25 August 2026 · Fusion42 review

The Federal Trade Commission (FTC) approved the final consent order for the merger between Ascension Health and AmSurg, ensuring competition concerns are addressed under regulatory oversight in the United States healthcare sector.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

Healthcare founders in the US face a sharper regulatory gatekeeper as FTC enforcement shapes merger approvals more stringently. You need to plan for compliance earlier to avoid costly delays or deal rejections.

◆ Coverage

1 source · 25 Aug 2026

◆ Related on Wire

◆ Topics

Healthftcmergerhealthcareantitrustregulation